局部給藥：全球市場

全球局部用藥市場預計到 2025 年將達到 2,229 億美元，高於 2026 年的 2,390 億美元，到 2031 年底將達到 3,623 億美元。

預計 2026 年至 2031 年的年複合成長率（CAGR）為 8.7%。

調查範圍

本報告概述了全球局部給藥市場，並分析了市場趨勢。報告包含2025年（基準年）的全球銷售額（單位：十億美元）以及2026年至2031年預測期間的銷售額預估值。市場按產品類型、藥物類別、最終用戶和地區進行細分。本研究涵蓋的地區包括北美、歐洲、亞太地區、中東和非洲以及南美，並聚焦於各地區的主要國家。

本報告重點關注影響市場和供應商格局的關鍵趨勢和挑戰。

報告最後對競爭格局進行了分析，顯示了全球局部用藥市場主要參與者的市場佔有率。報告也特別闢出一節，詳細介紹了市場領導者的概況。

報告內容

• 數據表 63 及補充表 55
• 全球局部用藥市場概況與分析
• 2025 年（基準年）市場規模估算及 2026 年至 2031 年預測。
• 目前市場規模、估算和成長預測，以及按產品類型、藥物類別、給藥途徑、最終用戶和地區分類的市場佔有率分析。
• 有關市場動態的事實和數據，包括主要市場促進因素、限制因素、挑戰和機會。
• 對宏觀經濟因素、美國關稅的影響以及從波特五力分析。
• 主要地區局部用藥產品監管環境概述
• 對新興技術和發展趨勢進行考察，包括先進配方、經皮吸收系統和新型給藥方法。
• 對局部用藥技術相關專利進行綜述，並分析近期趨勢。
• 競爭格局分析，包括市佔率排名、策略舉措和創業融資活動。
• 業界領導企業的公司簡介，包括 Galderma、Kenvue、Bayer AG、Haleon 和 AbbVie Inc.。

目錄

第1章：摘要整理

第2章 市場概覽

• 概述
• 宏觀經濟因素
• 波特五力分析

第3章 市場動態

• 市場動態
• 市場促進因素
• 皮膚病盛行率增加
• 患者越來越傾向選擇無痛治療
• 慢性病管理與高齡化社會
• 醫藥產業研發成長；
• 市場限制因素
• 皮膚滲透性的極限
• 皮膚刺激和過敏反應
• 先進配方研發成本高昂
• 監管和核准方面的挑戰
• 市場機遇
• 新興經濟體
• 藥物傳輸技術的進步

第4章 監管情勢

• 概述
• 美國
• 歐洲
• 亞太地區

第5章：新興科技與趨勢

• 利用微針進行藥物輸送
• 利用奈米顆粒的藥物遞送系統
• 智慧經皮吸收貼片和穿戴式系統
• 3D列印藥物傳輸系統
• 刺激響應型和緩釋系統
• 人工智慧（AI）在局部藥物傳遞的應用
• 專利分析
• 主要發現

第6章 市場區隔分析

• 細分市場
• 市場分析：依產品類型
• 半固態製劑
• 液體
• 經皮貼劑
• 固態劑型
• 市場分析：依藥物類別分類
• 皮質類固醇
• 抗發炎藥
• 抗感染藥物
• 止痛藥
• 其他
• 市場分析：依最終用戶分類
• 居家醫療
• 醫院和診所
• 燒傷護理中心
• 其他
• 按地區分類
• 市場分析：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 世界其他地區

第7章 競爭情勢

• 競爭分析
• 策略舉措
• Acquisitions
• Partnership and Collaborations
• Product Launches/Approvals

第8章附錄

• 調查方法
• 資訊來源
• 簡稱
• 公司簡介
• ABBVIE INC.
• ALMIRALL
• BAUSCH HEALTH COMPANIES INC.
• BAYER AG
• GALDERMA
• GLENMARK PHARMACEUTICALS LTD.
• GSK PLC
• HALEON PLC
• HISAMITSU PHARMACEUTICAL CO. INC.
• JOHNSON & JOHNSON SERVICES INC.
• KENVUE
• LEO PHARMA A/S
• SANOFI
• SOLVENTUM
• TEVA PHARMACEUTICAL INDUSTRIES LTD.
• Few Emerging Startups/Market Disruptors

The global topical drug delivery market was valued at $222.9 billion in 2025 and is estimated to increase from $239 billion in 2026 to reach $362.3 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.

Report Scope

The report provides an overview of the global topical drug delivery market and analyzes market trends. It includes global revenue ($ Billion) for the base year of 2025 and estimated revenue for the forecast period of 2026 through 2031. The market is segmented by product type, drug class, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on the major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape.

The report concludes with an analysis of the competitive landscape, which provides market shares for key participants in the global topical drug delivery market. It also includes a dedicated section of company profiles that covers details of leading companies in the market.

Report Includes

• 63 data tables and 55 additional tables
• An overview and analysis of the global topical drug delivery market
• Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
• Estimates of the current market size and growth prospects, with a market share analysis by product type, drug class, route of administration, end user, and region
• Facts and figures related to market dynamics, including key drivers, restraints, challenges, and opportunities
• Review of macroeconomic factors, U.S. tariff impacts, and insights derived from Porter's Five Forces analysis
• Overview of the regulatory landscape affecting topical drug delivery products across major regions
• Discussion of emerging technologies and developments, including advanced formulations, transdermal systems, and novel delivery approaches
• Patent review and analysis of recent developments related to topical drug delivery technologies
• Analysis of the competitive landscape, including market share rankings, strategic initiatives, and venture funding activity
• Company profiles of major players within the industry, including Galderma, Kenvue, Bayer AG, Haleon, and AbbVie Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Porter's Five Forces Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Prevalence of Skin Diseases
• Growing Patient Preference for Painless Treatments
• Chronic Disease Management and Aging Population
• Growth in Pharmaceutical R&D
• Market Restraints
• Limited Skin Permeability
• Skin Irritation and Allergic Reactions
• High Development Costs for Advanced Formulations
• Regulatory and Approval Challenges
• Market Opportunities
• Emerging Economies
• Technological Advances in Drug Delivery

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologiesand Developments

• Key Takeaways
• Microneedle-Based Drug Delivery
• Nanoparticle-Based Drug Delivery Systems
• Smart Transdermal Patches and Wearable Systems
• 3D-Printed Drug Delivery Systems
• Stimuli-Responsive and Controlled-Release Systems
• Artificial Intelligence (AI) in Topical Drug Delivery
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Semi-Solid Formulations
• Liquid Formulations
• Transdermal Patches
• Solid Formulations
• Market Analysis by Drug Class
• Key Takeaways
• Corticosteroids
• Anti-inflammatories
• Anti-infectives
• Analgesics
• Others
• Market Analysis by End User
• Key Takeaways
• Home Care Settings
• Hospitals and Clinics
• Burn Care Centers
• Others
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Acquisitions
• Partnership and Collaborations
• Product Launches/Approvals

Chapter 8 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBVIE INC.
• ALMIRALL
• BAUSCH HEALTH COMPANIES INC.
• BAYER AG
• GALDERMA
• GLENMARK PHARMACEUTICALS LTD.
• GSK PLC
• HALEON PLC
• HISAMITSU PHARMACEUTICAL CO. INC.
• JOHNSON & JOHNSON SERVICES INC.
• KENVUE
• LEO PHARMA A/S
• SANOFI
• SOLVENTUM
• TEVA PHARMACEUTICAL INDUSTRIES LTD.
• Few Emerging Startups/Market Disruptors

List of Tables

• Summary Table : Global Market for Topical Drug Delivery, by Region, Through 2031
• Table 1 : Topical Drug Delivery Intended for Several Skin Diseases
• Table 2 : World Economic Outlook Projections, 2024-2026
• Table 3 : Chronic Conditions in 2024
• Table 4 : Predicted GDP Growth Rates, by Region, 2026
• Table 5 : Patent Shares for Topical Drug Delivery, by Jurisdiction, 2025
• Table 6 : Global Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 7 : Global Market for Semi-Solid Formulations in Topical Drug Delivery, by Region, Through 2031
• Table 8 : Global Market for Liquid Formulations in Topical Drug Delivery, by Region, Through 2031
• Table 9 : Global Market for Transdermal Patches in Topical Drug Delivery, by Region, Through 2031
• Table 10 : Global Market for Solid Formulations in Topical Drug Delivery, by Region,Through 2031
• Table 11 : Global Market for Topical Drug Delivery, by Drug Class, Through 2031
• Table 12 : Global Market for Corticosteroids in Topical Drug Delivery, by Region,Through 2031
• Table 13 : Global Market for Anti-inflammatories in Topical Drug Delivery, by Region, Through 2031
• Table 14 : Global Market for Anti-infectives in Topical Drug Delivery, by Region,Through 2031
• Table 15 : Global Market for Analgesics in Topical Drug Delivery, by Region, Through 2031
• Table 16 : Global Market for Other Drug Classes in the Topical Drug Delivery, by Region, Through 2031
• Table 17 : Global Market for Topical Drug Delivery, by End User, Through 2031
• Table 18 : Global Market for Topical Drug Delivery for Home Care Settings, by Region, Through 2031
• Table 19 : Examples of Diseases Treated with Topical Therapies in Hospitals
• Table 20 : Global Market for Topical Drug Delivery for Hospitals and Clinics, by Region, Through 2031
• Table 21 : Global Market for Topical Drug Delivery for Burn Care Centers, by Region, Through 2031
• Table 22 : Global Market for Topical Drug Delivery for Other End Users, by Region,Through 2031
• Table 23 : Global Market for Topical Drug Delivery, by Region, Through 2031
• Table 24 : North American Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 25 : North American Market for Topical Drug Delivery, by Drug Class, Through 2031
• Table 26 : North American Market for Topical Drug Delivery, by End User, Through 2031
• Table 27 : North American Market for Topical Drug Delivery, by Country, Through 2031
• Table 28 : U.S. Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 29 : Canadian Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 30 : Mexican Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 31 : European Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 32 : European Market for Topical Drug Delivery, by Drug Class, Through 2031
• Table 33 : European Market for Topical Drug Delivery, by End User, Through 2031
• Table 34 : European Market for Topical Drug Delivery, by Country, Through 2031
• Table 35 : German Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 36 : U.K. Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 37 : French Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 38 : Italian Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 39 : Spanish Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 40 : Rest of Europe Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 41 : Asia-Pacific Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 42 : Asia-Pacific Market for Topical Drug Delivery, by Drug Class, Through 2031
• Table 43 : Asia-Pacific Market for Topical Drug Delivery, by End User, Through 2031
• Table 44 : Asia-Pacific Market for Topical Drug Delivery, by Country, Through 2031
• Table 45 : Chinese Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 46 : Japanese Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 47 : Indian Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 48 : South Korean Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 49 : Australian Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 50 : Rest of Asia-Pacific Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 51 : Rest of the World Market for Topical Drug Delivery, by Product Type, Through 2031
• Table 52 : Rest of the World Market for Topical Drug Delivery, by Drug Class, Through 2031
• Table 53 : Rest of the World Market for Topical Drug Delivery, by End User, Through 2031
• Table 54 : Global Ranking of Companies in the Topical Drug Delivery Market, 2025
• Table 55 : Acquisitions in Global Topical Drug Delivery Market, 2024-2025
• Table 56 : Collaborations in Global Topical Drug Delivery Market, 2023-2026
• Table 57 : Product Launches/Approval in Global Topical Drug Delivery Market, 2023-2026
• Table 58 : Information Sources Used for this Report
• Table 59 : Abbreviations Used in this Report
• Table 60 : AbbVie Inc.: Company Snapshot
• Table 61 : AbbVie Inc.: Financial Performance, FY 2024 and 2025
• Table 62 : AbbVie Inc.: Product Portfolio
• Table 63 : AbbVie Inc.: News/Key Developments, 2025
• Table 64 : Almirall : Company Snapshot
• Table 65 : Almirall : Financial Performance, FY 2024 and 2025
• Table 66 : Almirall : Product Portfolio
• Table 67 : Almirall : News/Key Developments, 2024-2025
• Table 68 : Bausch Health Companies Inc.: Company Snapshot
• Table 69 : Bausch Health Companies Inc.: Financial Performance, FY 2024 and 2025
• Table 70 : Bausch Health Companies Inc.: Product Portfolio
• Table 71 : Bausch Health Companies Inc.: News/Key Developments, 2023-2025
• Table 72 : Bayer AG: Company Snapshot
• Table 73 : Bayer AG.: Financial Performance, FY 2024 and 2025
• Table 74 : Bayer AG: Product Portfolio
• Table 75 : Bayer AG: News/Key Developments, 2023-2026
• Table 76 : Galderma: Company Snapshot
• Table 77 : Galderma: Financial Performance, FY 2024 and 2025
• Table 78 : Galderma: Product Portfolio
• Table 79 : Galderma: News/Key Developments, 2023-2025
• Table 80 : Glenmark Pharmaceuticals Ltd.: Company Snapshot
• Table 81 : Glenmark Pharmaceuticals Ltd.: Financial Performance, FY 2023 and 2024
• Table 82 : Glenmark Pharmaceuticals Ltd.: Product Portfolio
• Table 83 : Glenmark Pharmaceuticals Ltd.: News/Key Developments, 2023-2025
• Table 84 : GSK plc: Company Snapshot
• Table 85 : GSK plc: Financial Performance, FY 2024 and 2025
• Table 86 : GSK plc: Product Portfolio
• Table 87 : Haleon plc: Company Snapshot
• Table 88 : Haleon plc: Financial Performance, FY 2024 and 2025
• Table 89 : Haleon plc: Product Portfolio
• Table 90 : Haleon plc: News/Key Developments, 2025
• Table 91 : Hisamitsu Pharmaceutical Co. Inc.: Company Snapshot
• Table 92 : Hisamitsu Pharmaceutical Co. Inc.: Financial Performance, FY 2023 and 2024
• Table 93 : Hisamitsu Pharmaceutical Co. Inc.: Product Portfolio
• Table 94 : Hisamitsu Pharmaceutical Co. Inc.: News/Key Developments, 2023-2025
• Table 95 : Johnson & Johnson Services Inc.: Company Snapshot
• Table 96 : Johnson & Johnson Services Inc.: Financial Performance, FY 2024 and 2025
• Table 97 : Johnson & Johnson Services Inc.: Product Portfolio
• Table 98 : Johnson & Johnson Services Inc.: News/Key Developments, 2025-2026
• Table 99 : Kenvue: Company Snapshot
• Table 100 : Kenvue: Financial Performance, FY 2024 and 2025
• Table 101 : Kenvue: Product Portfolio
• Table 102 : Kenvue: News/Key Developments, 2024-2026
• Table 103 : LEO Pharma A/S: Company Snapshot
• Table 104 : LEO Pharma A/S: Financial Performance, FY 2024 and 2025
• Table 105 : LEO Pharma A/S: Product Portfolio
• Table 106 : LEO Pharma A/S: News/Key Developments, 2023-2025
• Table 107 : Sanofi: Company Snapshot
• Table 108 : Sanofi: Financial Performance, FY 2024 and 2025
• Table 109 : Sanofi: Product Portfolio
• Table 110 : Sanofi: News/Key Developments, 2025
• Table 111 : Solventum: Company Snapshot
• Table 112 : Solventum: Financial Performance, FY 2024 and 2025
• Table 113 : Solventum: Product Portfolio
• Table 114 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
• Table 115 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2024 and 2025
• Table 116 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
• Table 117 : List of a Few Emerging Startups/Market Disruptors

List of Figures

• Summary Figure : Summary Figure: Global Market Shares for Topical Drug Delivery, by Region, 2025
• Figure 1 : Porter's Five Forces Analysis of the Topical Drug Delivery Market
• Figure 2 : Market Dynamics of Global Topical Drug Delivery
• Figure 3 : Number of Patents for Topical Drug Delivery, by Leading Applicants in 2025
• Figure 4 : Patent Shares for Topical Drug Delivery, by Document Type, 2025
• Figure 5 : Global Market Shares for Topical Drug Delivery, by Product Type, 2025
• Figure 6 : Global Market Shares for Topical Drug Delivery, by Drug Class, 2025
• Figure 7 : Global Market Shares for Topical Drug Delivery, by End User, 2025
• Figure 8 : Global Market Shares for Topical Drug Delivery, by Region, 2025
• Figure 9 : AbbVie Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 10 : AbbVie Inc.: Revenue Shares, by Country/Region, FY 2025
• Figure 11 : Almirall : Revenue Shares, by Country/Region, FY 2025
• Figure 12 : Bausch Health Companies Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 13 : Bausch Health Companies Inc.: Revenue Shares, by Country/Region, FY 2025
• Figure 14 : Bayer AG: Revenue Shares, by Business Unit, FY 2025
• Figure 15 : Bayer AG: Revenue Shares, by Country/Region, FY 2025
• Figure 16 : GALDERMA: Revenue Shares, by Country/Region, FY 2025
• Figure 17 : Glenmark Pharmaceuticals Ltd.: Revenue Shares, by Country/Region, FY 2024
• Figure 18 : GSK plc: Revenue Shares, by Business Unit, FY 2025
• Figure 19 : GSK plc: Revenue Shares, by Country/Region, FY 2025
• Figure 20 : Haleon plc: Revenue Shares, by Business Unit, FY 2025
• Figure 21 : Haleon plc: Revenue Shares, by Country/Region, FY 2025
• Figure 22 : Johnson & Johnson Services Inc.: Revenue Shares, by Business Unit, FY 2025
• Figure 23 : Johnson & Johnson Services Inc.: Revenue Shares, by Country/Region, FY 2025
• Figure 24 : KENVUE: Revenue Shares, by Business Unit, FY 2025
• Figure 25 : KENVUE: Revenue Shares, by Country/Region, FY 2025
• Figure 26 : LEO Pharma A/S: Revenue Shares, by Business Unit, FY 2025
• Figure 27 : LEO Pharma A/S: Revenue Shares, by Country/Region, FY 2025
• Figure 28 : SANOFI: Revenue Shares, by Country/Region, FY 2025
• Figure 29 : SOLVENTUM: Revenue Shares, by Business Unit, FY 2025
• Figure 30 : SOLVENTUM: Revenue Shares, by Country/Region, FY 2025
• Figure 31 : Teva Pharmaceutical Industries Ltd.: Revenue Shares, by Country/Region, FY 2025